Gefitinib in a molecularly defined chemonaive population with advanced non-small-cell lung cancer

被引：1
|
作者：
Teck, Lim Wan [1 ]
Huat, Tan Bee [1 ]
Ravindran, Kanesvaran [1 ]
Balram, Chowbay [1 ]
机构：
[1] Natl Canc Ctr S, Div Med Sci, Clin Pharmacol Lab, Humphrey Oei Inst Canc Res, Singapore 169610, Singapore
来源：
PHARMACOGENOMICS | 2008年 / 9卷 / 10期
关键词：
D O I：
10.2217/14622416.9.10.1381
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1381 / 1382
页数：2
相关论文
共 50 条
  • [1] Gefitinib in the treatment of advanced non-small-cell lung cancer
    Reck, Martin
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (04) : 401 - 412
  • [2] Gefitinib for refractory advanced non-small-cell lung cancer
    Moriguchi, H
    Kim, TY
    Sato, C
    LANCET, 2006, 367 (9507): : 299 - 300
  • [3] Gefitinib therapy for advanced non-small-cell lung cancer
    Liu, CY
    Seen, S
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (11) : 1644 - 1653
  • [4] Gefitinib or docetaxel in advanced non-small-cell lung cancer
    Cullen, Michael
    Thatcher, Nicholas
    LANCET, 2008, 372 (9652): : 1785 - 1786
  • [5] Gefitinib: A new antineoplastic for advanced non-small-cell lung cancer
    Cersosimo, RJ
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (09) : 889 - 898
  • [6] Gefitinib for Chinese patients with advanced non-small-cell lung cancer
    Xiaotong, Z
    Longyun, L
    Xinlin, MU
    LUNG CANCER, 2004, 45 : S79 - S79
  • [7] EGFR mutational status and clinical outcome to gefitinib monotherapy in chemonaive non-small-cell lung cancer patients
    不详
    PHARMACOGENOMICS, 2008, 9 (10) : 1382 - 1382
  • [8] Erlotinib in advanced non-small-cell lung cancer after gefitinib failure
    Zheng-Tao Zhou
    Xin-Hua Xu
    Qing Wei
    Ming-qian Lu
    Jie Wang
    Cai-Hong Wen
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 1123 - 1127
  • [9] Comparison of Gefitinib and Erlotinib for Patients with Advanced Non-Small-Cell Lung Cancer
    Lee, Jin Hwa
    Lee, Kyoung Eun
    Ryu, Yon Ju
    Chun, Eun Mi
    Chang, Jung Hyun
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2009, 66 (04) : 280 - 287
  • [10] Erlotinib in advanced non-small-cell lung cancer after gefitinib failure
    Zhou, Zheng-Tao
    Xu, Xin-Hua
    Wei, Qing
    Lu, Ming-qian
    Wang, Jie
    Wen, Cai-Hong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (06) : 1123 - 1127
12345